| Israel Kirzner on coordination and discovery DB Klein, J Briggeman GMU Working Paper in Economics, 2009 | 32 | 2009 |
| Ideological profiles of the economics laureates AAAAB Buchanan, CDDEF Friedman, FGHHH Heckman, ... Econ journal watch 10 (3), 2013 | 17 | 2013 |
| Governance as a strategy in state-of-nature games J Briggeman Public Choice 141, 481-491, 2009 | 11 | 2009 |
| Searching for Justification of the Policy of Pre-Market Approval of Pharmaceuticals J Briggeman George Mason University, 2015 | 6 | 2015 |
| 305 Economists Called to Answer Questionnaire on the Pre-Market Approval of Drugs and Devices DB Klein, J Briggeman Econ Journal Watch 7 (1), 99-106, 2010 | 4 | 2010 |
| The Proper Role of the FDA for the 21st Century JV Gulfo, J Briggeman, EC Roberts Mercatus Research, Mercatus Center at George Mason University, 2016 | 3 | 2016 |
| Amartya Sen [Ideological Profiles of the Economics Laureates] J Briggeman Econ Journal Watch 10 (3), 604-616, 2013 | 3 | 2013 |
| Protecting cultural monuments against terrorism: a comment J Briggeman, J Horpedahl Defence and Peace Economics 20 (6), 509-512, 2009 | 3 | 2009 |
| Hume's Manuscript Account of the Extraordinary Affair Between Him and Rousseau. D Hume, DB Klein, J Briggeman, JR Hall Econ Journal Watch 18 (2), 286-327, 2021 | 2 | 2021 |
| Product approvability recommendations from FDA advisory committees: inconsistently sought, indirectly obtained JV Gulfo, J Briggeman, A Gamie Therapeutic Innovation & Regulatory Science 52 (6), 784-792, 2018 | 2 | 2018 |
| The proper role of the FDA for the 21st century J Briggeman, E Roberts, J Gulfo MERCATUS RESEARCH, 2016 | 2 | 2016 |
| America's' Top Economists' On the Spot: What Explains Their Low Opposition to a Minimum Wage Increase in 2013? J Briggeman Available at SSRN 2249040, 2013 | 2 | 2013 |
| 44 Economists Answer Questionnaire on the Pre-Market Approval of Drugs and Devices J Briggeman, DB Klein, KD Rollins Econ Journal Watch 7 (2), 162-173, 2010 | 2 | 2010 |
| 44 Transcripts: Economists Who Answered the Questionnaire on the Pre-Market Approval of Drugs and Devices J Briggeman, DB Klein, KD Rollins Econ Journal Watch 7 (2), A1-A124, 2010 | 2 | 2010 |
| Long-run determinants of economic growth: putterman and weil revisited J Briggeman Econ Journal Watch 19 (1), 85, 2022 | 1 | 2022 |
| Paul Krugman [Ideological Profiles of the Economics Laureates] J Briggeman Econ Journal Watch 10 (3), 400-410, 2013 | 1 | 2013 |
| Results of Survey of Economics Professors on Immigration, Drug, and Pharmaceutical Policies J Briggeman, WL Davis, DB Klein GMU Working Paper in Economics, 2017 | | 2017 |
| Are So-Called Normative Statements Practically the Same as Suitably Formulated So-Called Positive Statements? Evidence from a Survey of Economics Professors DB Klein, J Briggeman, WL Davis, A Devereaux GMU Working Paper in Economics, 2017 | | 2017 |
| A Cautionary Note on Measuring the Duration of FDA Drug and Device Reviews J Briggeman Available at SSRN 3780321, 2017 | | 2017 |
| How Productive Is the FDA? s Devices Program? J Briggeman George Mason University, Mercatus Center Working Papers, 2016 | | 2016 |
